People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | — | Biotechnology | Series C | $85.4M | $3.5B | 2018 |
Virgil Bryan Lawlis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Virgil Bryan Lawlis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John G. Freund | 1 | 6 |
| William J. Newell | 1 | 3 |
| Armen G. Shanafelt | 1 | 2 |
| Joseph Bryan Lobacki | 1 | 1 |
| Daniel J. Janney | 1 | 1 |
| Armen Bryan Shanafelt | 1 | 1 |
| Michael Bryan Dybbs | 1 | 1 |
| Michael Bryan Ross | 1 | 1 |
| Daniel Bryan Petree | 1 | 1 |
| Michael G. Ross | 1 | 1 |
| Bryan G. Lawlis | 1 | 1 |
| Joseph G. Lobacki | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.